CAP: A novel era to better quantitate fatty liver?

Journal of Gastrointestinal and Liver Diseases

Volumn 24, Issue 1, 2015, Pages 11-13

  Mueller, Sebastian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE;

ALCOHOL CONSUMPTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED ATTENUATION PARAMETER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE COURSE; ECHOGRAPHY; EDITORIAL; ENVIRONMENTAL FACTOR; FAT INTAKE; FATTY ACID OXIDATION; FATTY LIVER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPOLYSIS; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; VIRUS HEPATITIS; ELASTOGRAPHY; FEMALE; LIVER; MALE; PROCEDURES;

ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE;

EID: 84924106531     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Seitz HK, Mueller S. Alcoholic liver disease. In: Dancygier H, ed. Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases. Heidelberg, Dordrecht, London, New York: Springer, 2009: 1111-1152.
2. Bellentani S, Saccoccio G, Costa G, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997; 41: 845-850. doi: 10. 1136/gut. 41. 6. 845.
3. Frerichs TF. Klinik der Leberkrankheiten. Braunschweig: Vieweg, 1858.
4. Seitz HK, Mueller S. Ethanol metabolism and its consequences. In: Anzenbacher P, Zanger U, eds. Metabolism of Drugs and Xenobiotics. Weinheim: Wiley, 2011.
5. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party? Hepatology 1998; 27: 1463-1466. doi: 10. 1002/hep. 510270601.
6. Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-1465. doi: 10. 1038/ng. 257.
7. Rausch V, Straub BK, Peccerella T, et al. Primary hepatocellular damage lowers alcohol consumption and suppresses fat mobilization in heavy drinkers with PNPLA3 G genotype (submitted), 2015.
8. Mathurin P, Beuzin F, Louvet A, et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther 2007; 25: 1047-1054. doi: 10. 1111/j. 1365-2036. 2007. 03302. x.
9. Mueller S, Seitz HK, Rausch V. Non-invasive diagnosis of alcoholic liver disease. World J Gastroenterol 2014; 20: 14626-14641. doi: 10. 3748/wjg. v20. i40. 14626.
10. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009; 51: 433-445. doi: 10. 1016/j. jhep. 2009. 05. 023.
11. d'Assignies G, Ruel M, Khiat A, et al. Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods Eur Radiol 2009; 19: 2033-2040. doi: 10. 1007/s00330-009-1351-4.
12. Sasso M, Beaugrand M, de Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010; 36: 1825-1835. doi: 10. 1016/j. ultrasmedbio. 2010. 07. 005.
13. Lupşor-Platon M, Feier D, Stefănescu H, et al. Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study. J Gastrointestin Liver Dis 2015; 24: 35-42.